The Patented Medicine Prices Review Board (PMPRB) has released its April 2016 NEWSletter. Some recent changes include:
Public Consultation on PMPRB ... Read More
News
03
May2016
22
Apr2016
To meet the needs of Quebec’s Ministry of Health and Social Services (MSSS), the Institut national d’excellence en santé et ... Read More
19
Apr2016
The pan-Canadian Pharmaceutical Alliance (pCPA) Releases its April 1st, 2016 Update
/ pCPA, What's New
On April 1, 2016, the pan-Canadian Pharmaceutical Alliance (pCPA) issued the First Principles for Subsequent Entry Biologics (SEBs) to guide ... Read More
11
Apr2016
On April 1, 2016, the pan-Canadian Pharmaceutical Alliance (pCPA) issued manufacturers a notification of first principles for subsequent entry biologics ... Read More
30
Mar2016
New Implementation Dates for Revisions to the Procedure for Voluntary Withdrawal and Providing CDR Review Team’s Responses
/ CADTH, CDEC, CDR, What's New
Due to a high workload volume and ensuring submissions are reviewed in a timely manner, CADTH is deferring the effective ... Read More
30
Mar2016
Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs
/ CADTH, CDEC, CDR, pCODR, What's New
Recommendation Framework for CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) Programs
In collaboration with the participating jurisdictions ... Read More
24
Mar2016
The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016
/ PMPRB, What's New
In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on ... Read More
24
Mar2016
Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products
/ CDR, Ontario, pCODR, What's New
Effective April 1, 2016, all drug products reviewed by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review ... Read More